Nitric oxide dilates rat retinal blood vessels by cyclooxygenase-dependent mechanisms

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 297, Issue 4, 2009, Pages

  Ogawa, Naoto ^a   Mori, Asami ^a   Hasebe, Masami ^a   Hoshino, Maya ^a   Saito, Maki ^a   Sakamoto, Kenji ^a   Nakahara, Tsutomu ^a   Ishii, Kunio ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Cyclooxygenases; Prostaglandins; Retinal blood vessel

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; 8 (4 CHLOROPHENYLTHIO) CYCLIC GMP; 9 (TETRAHYDRO 2 FURYL)ADENINE; AMIDE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ETHYL 2 (HYDROXYAMINO) 5 NITRO 3 HEXENAMIDE; GUANYLATE CYCLASE; HYDRALAZINE; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; NOR 3; TETRODOTOXIN; THIOBUTABARBITAL; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL DIAMETER; BLOOD VESSEL REACTIVITY; CHOROID; CONTROLLED STUDY; EYE FUNDUS; EYE PHOTOGRAPHY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MESENTERY BLOOD VESSEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RAT; RETINA; RETINA BLOOD VESSEL; SIGNAL TRANSDUCTION; VASODILATATION;

ADENYLATE CYCLASE; ANESTHETICS, LOCAL; ANIMALS; ARTERIOLES; BLOOD PRESSURE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; GUANYLATE CYCLASE; HEART RATE; MALE; MEMBRANE PROTEINS; NITRIC OXIDE; NITRIC OXIDE DONORS; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RETINAL VESSELS; TIME FACTORS; VASODILATION; VASODILATOR AGENTS; VENULES;

EID: 70349630426     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.91005.2008     Document Type: Article

References (32)

1. Boje KM, Jaworowicz D Jr, Raybon JJ. Neuroinflammatory role of prostaglandins during experimental meningitis: evidence suggestive of an in vivo relationship between nitric oxide and prostaglandins. J Pharmacol Exp Ther 304: 319-325, 2003.
2. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368: 850-853, 1994. (Pubitemid 24137748)
3. Chemtob S, Beharry K, Rex J, Chatterjee T, Varma DR, Aranda JV. Ibuprofen enhances retinal and choroidal blood flow autoregulation in newborn piglets. Invest Ophthalmol Vis Sci 32: 1799 - 1807, 1991.
4. G-nitro-L-arginine-treated rats. J Cardiovasc Pharmacol 35: 630-637, 2000.
5. Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46: 205-229, 1994. (Pubitemid 24185151)
6. Ding JD, Weinberg RJ. Distribution of soluble guanylyl cyclase in rat retina. J Comp Neurol 500: 734-745, 2007. (Pubitemid 46067786)
7. Ehrlich K, Sicking C, Respondek M, Peskar BM. Interaction of cyclooxygenase isoenzymes, nitric oxide, and afferent neurons in gastric mucosal defense in rats. J Pharmacol Exp Ther 308: 277-283, 2004. (Pubitemid 38090728)
8. Furukawa K, Itoh T, Kajiwara M, Kitamura K, Suzuki H, Ito Y, Kuriyama H. Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries. J Pharmacol Exp Ther 218: 248-259, 1981. (Pubitemid 11033747)
9. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol 48: 184-188, 1995.
10. Hardy P, Abran D, Hou X, Lahaie I, Peri KG, Asselin P, Varma DR, Chemtob S. A major role for prostacyclin in nitric oxide-induced ocular vasorelaxation in the piglet. Circ Res 83: 721-729, 1998. (Pubitemid 28462786)
11. Haslam RJ, Davidson MM, Desjardins JV. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Biochem J 176: 83-95, 1978.
12. Ju WK, Neufeld AH. Cellular localization of cyclooxygenase-1 and cyclooxygenase-2 in the normal mouse, rat, and human retina. J Comp Neurol 452: 392-399, 2002. (Pubitemid 35154500)
13. Ju WK, Kim KY, Neufeld AH. Increased activity of cyclooxygenase-2 signals early neurodegenerative events in the rat retina following transient ischemia. Exp Eye Res 77: 137-145, 2003.
14. Koss MC. Functional role of nitric oxide in regulation of ocular blood flow. Eur J Pharmacol 374: 161-174, 1999. (Pubitemid 29287131)
15. Kukovetz WR, Holzmann S, Braida C, Poch G. Dual mechanism of the relaxing effect of nicorandil by stimulation of cyclic GMP formation and by hyperpolarization. J Cardiovasc Pharmacol 17: 627-633, 1991.
16. Ca) in smooth muscle cells isolated from the rat mesenteric artery. Br J Pharmacol 124: 1131-1140, 1998.
17. Mollace V, Muscoli C, Masini E, Cuzzocrea S, Salvemini D. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 57: 217-252, 2005. (Pubitemid 41043885)
18. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology pathophysiology, pharmacology. Pharmacol Rev 43: 109-142, 1991.
19. Mori A, Saito M, Sakamoto K, Nakahara T, Ishii K. Intravenously administered vasodilatory prostaglandins increase retinal and choroidal blood flow in rats. J Pharm Sci 103: 103-112, 2007. (Pubitemid 46175600)
20. 2 receptors dilates retinal arterioles and increases retinal and choroidal blood flow in rats. Eur J Pharmacol 570: 135-141, 2007.
21. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures properties, function. Physiol Rev 79: 1193-1226, 1999. (Pubitemid 29473315)
22. Ogawa N, Saito M, Mori A, Sakamoto K, Kametaka S, Nakahara T, Ishii K. Vasodilator effect of nicorandil on retinal blood vessels in rats. Naunyn-Schmiedeberg's Arch Pharmacol 375: 323-328, 2007. (Pubitemid 46945335)
23. Riva CE, Sinclair SH, Grunwald JE. Autoregulation of retinal circulation in response to decrease of perfusion pressure. Invest Ophthalmol Vis Sci 21: 34-38, 1981.
24. Robinson F, Riva CE, Grunwald JE, Petrig BL, Sinclair SH. Retinal blood flow autoregulation in response to an acute increase in blood pressure. Invest Ophthalmol Vis Sci 27: 722-726, 1986. (Pubitemid 16080489)
25. Sakamoto K, Yonoki Y, Kuwagata M, Saito M, Nakahara T, Ishii K. Histological protection against ischemia-reperfusion injury by early ischemic preconditioning in rat retina. Brain Res 1015: 154-160, 2004. (Pubitemid 38829749)
26. Salvemini D. Regulation of cyclooxygenase enzymes by nitric oxide. Cell Mol Life Sci 53: 576-582, 1997. (Pubitemid 27385181)
27. Salvemini D, Currie MG, Mollace V. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators. J Clin Invest 97: 2562-2568, 1996. (Pubitemid 26191120)
28. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90: 7240-7244, 1993. (Pubitemid 23222425)
29. Sugimoto Y, Narumiya S. Prostaglandin E receptors. J Biol Chem 282: 11613-11617, 2007.
30. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 63:18J-24J, 1989. (Pubitemid 19161045)
31. 2 contributes to the vasodepressor effect of baicalein in hypertensive rats. Hypertension 31: 866-871, 1998.
32. G-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release. J Pharmacol Exp Ther 257:1208-1215, 1991.